|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7048 | |
| A61K 45/06 | |||
| A61P 3/10 | |||
| A61P 15/10 | |||
| A61K 31/5575 |
| (11) | Number of the document | 3288561 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16719399.4 |
| Date of filing the European patent application | 2016-04-28 | |
| (97) | Date of publication of the European application | 2018-03-07 |
| (45) | Date of publication and mention of the grant of the patent | 2021-03-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/059525 |
| Date | 2016-04-28 |
| (87) | Number | WO 2016/174155 |
| Date | 2016-11-03 |
| (30) | Number | Date | Country code |
| 15166057 | 2015-04-30 | EP |
| (72) |
MAYOUX, Eric Williams, DE
BEHR-ROUSSEL, Delphine, FR
GIULIANO, Francois, FR
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | METHODS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SGLT2 INHIBITOR FOR TREATING OR IMPROVING ERECTILE DYSFUNCTION |
| METHODS AND PHARMACEUTICAL COMPOSITIONS COMPRISING A SGLT2 INHIBITOR FOR TREATING OR IMPROVING ERECTILE DYSFUNCTION |